DASHENLIN PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.32 CNY | +0.09% |
|
+7.05% | -10.36% |
| Mar. 18 | Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares | MT |
| Mar. 05 | Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares | MT |
Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.
a767f21ff18f9f241fdbe524e106.eyxdz5VUwJUphMnn3kFmmB-v7PNaUqbfcM7Bui4HhPc.I2Jo4qQficAczaukqhIu_1adn4kqOd6OAfuvwwM29I0tZSu70Xnw7R3Log~e7f6a9a80a236af90be668f028efa373
Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.
Past events on DaShenLin Pharmaceutical Group Co., Ltd.
| 2024-03-31 10:30 pm | Extraordinary Shareholders Meeting |
| 2024-02-07 09:30 pm | Extraordinary Shareholders Meeting |
| 2023-12-28 09:30 pm | Extraordinary Shareholders Meeting |
| 2023-10-30 | Q3 2023 Earnings Release |
| 2023-08-29 | Q2 2023 Earnings Release |
| 2023-05-18 10:30 pm | Annual General Meeting |
| 2023-04-27 | Q4 2022 Earnings Release |
| 2023-04-27 | Q1 2023 Earnings Release |
| 2023-04-11 10:30 pm | Extraordinary Shareholders Meeting |
| 2023-03-12 10:30 pm | Extraordinary Shareholders Meeting |
| 2023-02-02 09:30 pm | Extraordinary Shareholders Meeting |
| 2022-10-27 | Q3 2022 Earnings Release |
| 2022-08-29 | Interim 2022 Earnings Release |
| 2022-05-19 10:30 pm | Annual General Meeting |
| 2022-04-27 | Q1 2022 Earnings Release |
| 2022-04-27 | FY 2021 Earnings Release |
| 2022-03-20 10:30 pm | Extraordinary Shareholders Meeting |
| 2021-10-27 | Q3 2021 Earnings Release |
| 2021-08-29 | Interim 2021 Earnings Release |
| 2021-07-01 10:30 pm | Extraordinary Shareholders Meeting |
Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.
| 2023-06-08 | Annual 0.6 CNY |
| 2022-06-12 | Annual 0.5 CNY |
| 2021-06-09 | Annual 0.8 CNY |
| 2020-06-16 | Annual 0.6 CNY |
| 2019-05-29 | Annual 0.6 CNY |
| 2018-06-18 | Annual 0.6 CNY |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 8 859 8 860 -0% | 11 141 11 059 0.74% | 14 583 14 501 0.57% | 16 759 17 442 -3.91% | 21 248 20 468 3.81% | 24 720 |
|
EBITDA Million CNY | Released Forecast Spread | 956 863 10.79% | 1 211 947 27.87% | 1 788 1 660 7.67% | 2 408 1 775 35.63% | 1 883 2 263 -16.81% | 2 525 |
|
EBIT Million CNY | Released Forecast Spread | 718 727 -1.2% | 918 914 0.5% | 1 448 1 415 2.35% | 1 041 1 452 -28.35% | 1 421 1 493 -4.85% | 1 863 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 720 729 -1.23% | 919 914 0.63% | 1 446 1 421 1.81% | 1 044 1 469 -28.94% | 1 415 1 477 -4.18% | 1 806 |
|
Net income Million CNY | Released Forecast Spread | 532 544 -2.25% | 703 671 4.67% | 1 062 1 058 0.39% | 791 1 093 -27.58% | 1 036 1 098 -5.65% | 1 306 |
|
EPS CNY | Released Forecast Spread | 0,49 0,50 -2.2% | 0,61 0,67 -8.96% | 0,94 0,93 0.42% | 0,69 1,00 -30.62% | 0,91 0,98 -7.38% | 1,15 |
| Announcement Date | 04/03/19 | 28/04/20 | 19/04/21 | 27/04/22 | 27/04/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 4 301 4 275 0.6% | 4 404 4 891 -9.95% | 4 677 4 986 -6.21% | 5 044 4 705 7.21% | 5 097 5 231 -2.56% | 6 430 5 872 9.51% | 5 947 5 929 0.31% | 6 045 6 350 -4.8% | 5 731 6 269 -8.57% | 6 760 | 6 842 | 7 121 | 7 384 | 8 553 |
|
EBITDA Million CNY | Released Forecast Spread | 301 533 -43.67% | 340 | 614 579 5.99% | 499 681 -26.83% | 427 703 -39.25% | 654 | 891 | 864 | 796 | 547 | 930 | 977 | 977 | 1 024 |
|
EBIT Million CNY | Released Forecast Spread | 224 439 -48.9% | -41,4 268 -115.48% | 492 452 9% | 439 410 7.07% | 292 | 198 246 -19.67% | 684 574 19.19% | 577 544 5.95% | 372 419 -11.39% | 182 | 541 | 554 | 581 | 637 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 225 419 -46.35% | -34,4 239 -114.38% | 494 418 18.07% | 443 306 44.93% | 289 325 -11.33% | 189 301 -37.31% | 679 461 47.28% | 547 472 15.86% | 364 397 -8.36% | 165 | 509 | 554 | 554 | 598 |
|
Net income Million CNY | Released Forecast Spread | 173 310 -44.34% | -27,1 170 -115.92% | 384 308 24.88% | 330 227 45.61% | 209 241 -13.28% | 112 214 -47.36% | 497 341 45.78% | 421 342 22.95% | 257 271 -5.25% | 97,3 | 470 | 401 | 401 | 433 |
|
EPS CNY | Released Forecast Spread | 0,16 0,29 -44.75% | -0,03 0,17 -120.6% | 0,34 0,28 21.1% | 0,28 0,25 16.07% | 0,18 | 0,10 0,17 -40.51% | 0,43 0,43 -0% | 0,38 0,37 2.05% | 0,22 0,22 1.84% | 0,10 | 0,32 | 0,30 | 0,31 | 0,45 |
| Announcement Date | 27/10/21 | 27/04/22 | 27/04/22 | 29/08/22 | 27/10/22 | 27/04/23 | 27/04/23 | 29/08/23 | 30/10/23 | - | - | - | - | - |
More events
Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.
| 2024-04-17 | CLICKS GROUP LIMITED: Q2 2024 Earnings Release (Projected) |
| 2024-04-16 12:57 am | DOCMORRIS AG: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-04-07 | WELCIA HOLDINGS CO., LTD.: Q4 2024 Earnings Release |
| 2024-03-28 07:00 am | WALGREENS BOOTS ALLIANCE, INC.: Q2 2024 Earnings Release |
| 2024-03-21 02:00 am | DOCMORRIS AG: Q4 2023 Earnings Release |
| 2024-03-20 06:00 am | JD HEALTH INTERNATIONAL INC.: Q4 2023 Earnings Release |
| 2024-03-19 | SOPHARMA AD: February 2024 Sales and Revenue Release |
| 2024-03-18 | SIPAI HEALTH TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-18 08:50 am | AL-DAWAA MEDICAL SERVICES COMPANY: Q4 2023 Earnings Release |
| 2024-03-17 10:01 am | NAHDI MEDICAL COMPANY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603233 Stock
- Calendar DaShenLin Pharmaceutical Group Co., Ltd.
